FDA Approval Granted for First Long-acting Injectable HIV Therapy
Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 25, 2021
US confirmed cases of COVID-19 have surpassed 25 million; global cases have reached 99 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Seen in the ED: Fever, Joint Pain, and Positive Jolt Sign in a Young Man
Fever is up to 103.5°F, joint pain is affecting lower extremities, bilaterally, and the patient complains of headache. Could sex have anything to do with it?
FDA Update: Blood Donation During COVID-19 Pandemic
The FDA provides details on how COVID-19 infection or vaccination against the virus affects a waiting period to donate. Please share the information with your patients.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 22, 2021
Global confirmed cases of COVID-19 have surpassed 97 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
7 Myths and Facts about the COVID-19 Vaccines for PCPs and Patients
Patients trust primary care providers for accurate information on the COVID-19 vaccines. Here are 7 of the many myths now widespread you may need to explain to your patients.
Pfizer-BioNTech COVID-19 Vaccine Found Effective Against UK Variant
Results from a new study confirm that the Pfizer-BioNTech COVID-19 vaccine works against the fast-spreading UK variant of SARS-CoV-2.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 21, 2021
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
A Doctor's Doctor Counsels on the Decision to Leave Practice
Michael Myers, MD, a physician to physicians, urges any clinician who, worn out by COVID-19, has thoughts of leaving medicine to seek counseling first.
Thirty-day Readmission Rate Higher for CVD Patients Who Believe it will Happen
Thirty-day hospital readmission was found to be higher among cardiovascular patients who believed readmission was highly likely vs those who did not believe so.
PCP Survey Finds Patient Vaccine Distrust High, Health Issues More Complex
A majority of primary care clinicians report their patients worry about COVID-19 vaccine side effects and the speed of vaccine development. Most do plan to be vaccinated themselves.
Alcohol Intake Rising among US Adults with Anxiety, Depression during COVID-19
Adults with anxiety and depression are more likely to report an increase in drinking during the COVID-19 pandemic vs those without mental health issues, a new study found.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 20, 2021
Hospitalized COVID-19 Patients Still Face Cardiovascular Challenges after Discharge, Study Finds
New research from the United Kingdom found that COVID-19 patients discharged from the hospital still face a heightened risk of experiencing a major adverse cardiovascular event.
The View from One Hospital's COVID-19 Trenches
The bad news, writes ID expert and AIDS researcher Rodger MacArthur, MD, is the New Year's surge in his hospital's COVID-19 cases. The good news? Vaccines.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 19, 2021
Fighting COVID-19 Leaves Many in Health Care Suffering Moral Injury
Treating COVID-19 patients under the most challenging physical and emotional conditions has led to a sense of moral injury for many providers, according to Dr Michael Myers.
MJH Hosts Free Webinar on Emerging COVID-19 Variants
A trio of experts will discuss the emerging COVID-19 variants B.1.1.7 and B.1.351 in a free, one-hour live webinar event.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 18, 2021
Global confirmed cases of COVID-19 have surpassed 95 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
J&J COVID-19 Single-dose Vaccine Candidate Shows Promise
Johnson & Johnson single-dose COVID-19 vaccine candidate induces durable immune response in participants aged 18 to 55 years; results support further development.